Related Experiment Videos
Astilbin Alleviates Gouty Arthritis via Regulating NLRP3 Inflammasome and NF-κB Signaling Pathway: A Comprehensive
Xiaoxi Zhang1,2, Gaoyang Fu1, Xinyu Zhao1
1Department of Food Science and Nutrition, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Nutrients
|July 28, 2026
Summary
Astilbin, a natural compound, effectively reduces gouty arthritis symptoms by inhibiting key inflammatory pathways. This research highlights its potential as a novel treatment for this condition.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Background:
- Gouty arthritis (GA) is an inflammatory condition linked to purine metabolism.
- Current gout treatments have limitations, necessitating new therapeutic strategies.
- Astilbin, a flavonoid from Smilax glabra Roxb., shows promise for treating GA.
Purpose of the Study:
- To investigate the anti-gouty arthritis effects of astilbin.
- To elucidate the molecular mechanisms underlying astilbin's action in GA.
Main Methods:
- Established a mouse model of monosodium urate (MSU)-induced arthritis.
- Utilized mouse bone marrow-derived macrophages (BMDMs) for in vitro studies.
- Assessed joint swelling, inflammatory cell infiltration, and inflammatory factor expression (IL-1β, IL-6, TNF-α).
Main Results:
- Astilbin reduced MSU-induced joint swelling and inflammation in mice.
- Astilbin restored cell viability and inhibited inflammatory factors (IL-1β, IL-6, TNF-α).
- Astilbin suppressed NLRP3 inflammasome and NF-κB pathway activation (NLRP3, P-p65, ASC, P-IKKα, P-IκBα, cleaved-caspase-1).
Conclusions:
- Astilbin demonstrates significant anti-inflammatory effects in experimental models of gouty arthritis.
- Astilbin inhibits the activation of the NLRP3 inflammasome and NF-κB signaling pathway.
- Astilbin is a potential natural product candidate for the treatment of gouty arthritis.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...